British Journal of Cancer - Table of Contents alert Volume 115 Issue 7

If you are unable to see the message below, click here to view.

Advertisement nature.com webcasts Springer Nature presents a custom webcast on: Reveal hidden genetic variation by combining long-read target capture with SMRT Sequencing Date: Thursday October 13, 2016 Time: 8AM PDT, 11AM EDT, 4PM BST, 5PM CEST  Register for FREE Sponsored by: PacBio   TABLE OF CONTENTS Volume 115, Issue 7 (761-908) Published online 27 September 2016 In this issue Review Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Review Top Transforming growth factor β as regulator of cancer stemness and metastasis Claudia Bellomo, Laia Caja and Aristidis Moustakas Br J Cancer 2016 115: 761-769; advance online publication, August 18, 2016; 10.1038/bjc.2016.255 Abstract | Full Text Clinical Studies Top Fast-track access to urologic care for patients with macroscopic haematuria is efficient and cost-effective: results from a prospective intervention study Fredrik Liedberg, Ulf Gerdtham, Katarina Gralén, Sigurdur Gudjonsson, Staffan Jahnson, Irene Johansson, Oskar Hagberg, Staffan Larsson, Anna-Karin Lind, Annica Löfgren, Jenny Wanegård, Hanna Åberg and Mef Nilbert Br J Cancer 2016 115: 770-775; advance online publication, August 25, 2016; 10.1038/bjc.2016.265 Abstract | Full Text Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers Jon G Jonasson, Olafur A Stefansson, Oskar T Johannsson, Helgi Sigurdsson, Bjarni A Agnarsson, Gudridur H Olafsdottir, Kristin K Alexiusdottir, Hrefna Stefansdottir, Rodrigo Munoz Mitev, Katrin Olafsdottir, Kristrun Olafsdottir, Adalgeir Arason, Vigdis Stefansdottir, Elinborg J Olafsdottir, Rosa B Barkardottir, Jorunn E Eyfjord, Steven A Narod and Laufey Tryggvadóttir Br J Cancer 2016 115: 776-783; advance online publication, August 18, 2016; 10.1038/bjc.2016.249 Abstract | Full Text A multicentre phase II trial of cabazitaxel in patients with advanced non-small-cell lung cancer progressing after docetaxel-based chemotherapy A Kotsakis, A Matikas, F Koinis, N Kentepozidis, I I Varthalitis, V Karavassilis, Ep Samantas, P Katsaounis, E K Dermitzaki, D Hatzidaki, D Mavroudis and V Georgoulias Br J Cancer 2016 115: 784-788; advance online publication, September 8, 2016; 10.1038/bjc.2016.281 Abstract | Full Text Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer Angus G Dalgleish, Justin Stebbing, Douglas JA Adamson, Seema Safia Arif, Paolo Bidoli, David Chang, Sue Cheeseman, Robert Diaz-Beveridge, Carlos Fernandez-Martos, Rob Glynne-Jones, Cristina Granetto, Bartomeu Massuti, Karen McAdam, Raymond McDermott, Andrés J Muñoz Martín, Demetris Papamichael, Roberto Pazo-Cid, Jose M Vieitez, Alberto Zaniboni, Kevin J Carroll, Shama Wagle, Andrew Gaya and Satvinder S Mudan Br J Cancer 2016 115: 789-796; advance online publication, September 6, 2016; 10.1038/bjc.2016.271 Abstract | Full Text Translational Therapeutics Top Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma Sari F Alhasan, Beate Haugk, Laura F Ogle, Gary S Beale, Anna Long, Alastair D Burt, Dina Tiniakos, Despina Televantou, Fareeda Coxon, David R Newell, Richard Charnley and Helen L Reeves Br J Cancer 2016 115: 797-804; advance online publication, August 25, 2016; 10.1038/bjc.2016.264 Abstract | Full Text Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer Ana Luiza Ribeiro de Souza, Kayla Marra, Jason Gunn, Kimberley S Samkoe, Stephen Chad Kanick, Scott C Davis, M Shane Chapman, Edward V Maytin, Tayyaba Hasan and Brian W Pogue Br J Cancer 2016 115: 805-813; advance online publication, August 30, 2016; 10.1038/bjc.2016.267 Abstract | Full Text γ-Tocotrienol suppresses growth and sensitises human colorectal tumours to capecitabine in a nude mouse xenograft model by down-regulating multiple molecules Sahdeo Prasad, Subash C Gupta, Amit K Tyagi and Bharat B Aggarwal Br J Cancer 2016 115: 814-824; advance online publication, August 30, 2016; 10.1038/bjc.2016.257 Abstract | Full Text Molecular Diagnostics Top Delayed DNA double-strand break repair following platin-based chemotherapy predicts treatment response in head and neck squamous cell carcinoma S A Bhide, K Thway, J Lee, K Wong, P Clarke, K L Newbold, C M Nutting and K J Harrington Br J Cancer 2016 115: 825-830; advance online publication, September 1, 2016; 10.1038/bjc.2016.266 Abstract | Full Text Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer A C Rogers, D C Winter, A Heeney, D Gibbons, A Lugli, G Puppa and K Sheahan Br J Cancer 2016 115: 831-840; advance online publication, September 6, 2016; 10.1038/bjc.2016.274 Abstract | Full Text Impact of non-neoplastic vs intratumoural hepatitis B viral DNA and replication on hepatocellular carcinoma recurrence Qin Wang, Luan Lin, Seungyeul Yoo, Wenhui Wang, Sima Blank, M Isabel Fiel, Hena Kadri, Wei Luan, Leslie Warren, Jun Zhu and Spiros P Hiotis Br J Cancer 2016 115: 841-847; advance online publication, August 18, 2016; 10.1038/bjc.2016.239 Abstract | Full Text A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics Farshad Farshidfar, Aalim M Weljie, Karen A Kopciuk, Robert Hilsden, S Elizabeth McGregor, W Donald Buie, Anthony MacLean, Hans J Vogel and Oliver F Bathe Br J Cancer 2016 115: 848-857; advance online publication, August 25, 2016; 10.1038/bjc.2016.243 Abstract | Full Text Epidemiology Top Relationship between physician and patient assessment of performance status and survival in a large cohort of patients with haematologic malignancies Michael A Liu, Tammy Hshieh, Nolan Condron, Martha Wadleigh, Gregory A Abel and Jane A Driver Br J Cancer 2016 115: 858-861; advance online publication, August 23, 2016; 10.1038/bjc.2016.260 Abstract | Full Text Mediterranean diet and colorectal cancer risk: a pooled analysis of three Italian case–control studies Valentina Rosato, Valentina Guercio, Cristina Bosetti, Eva Negri, Diego Serraino, Attilio Giacosa, Maurizio Montella, Carlo La Vecchia and Alessandra Tavani Br J Cancer 2016 115: 862-865; advance online publication, August 18, 2016; 10.1038/bjc.2016.245 Abstract | Full Text Do colorectal cancer patients diagnosed as an emergency differ from non-emergency patients in their consultation patterns and symptoms? A longitudinal data-linkage study in England C Renzi, G Lyratzopoulos, T Card, T P C Chu, U Macleod and B Rachet Br J Cancer 2016 115: 866-875; advance online publication, August 18, 2016; 10.1038/bjc.2016.250 Abstract | Full Text Is cancer survival associated with cancer symptom awareness and barriers to seeking medical help in England? An ecological study Maja Niksic, Bernard Rachet, Stephen W Duffy, Manuela Quaresma, Henrik Møller and Lindsay JL Forbes Br J Cancer 2016 115: 876-886; advance online publication, August 18, 2016; 10.1038/bjc.2016.246 Abstract | Full Text The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer Jörg Kleeff, Eithne Costello, Richard Jackson, Chris Halloran, William Greenhalf, Paula Ghaneh, Richard F Lamb, Markus M Lerch, Julia Mayerle, Daniel Palmer, Trevor Cox, Charlotte L Rawcliffe, Oliver Strobel, Markus W Büchler and John P Neoptolemos for the European Study Group for Pancreatic Cancer Br J Cancer 2016 115: 887-894; advance online publication, September 1, 2016; 10.1038/bjc.2016.277 Abstract | Full Text Use of sildenafil or other phosphodiesterase inhibitors and risk of melanoma Anton Pottegård, Sigrún Alba Johannesdottir Schmidt, Anne Braae Olesen, Ninah Achacoso, Stephen K Van Den Eeden, Jesper Hallas, Henrik Toft Sørensen, Søren Friis and Laurel A Habel Br J Cancer 2016 115: 895-900; advance online publication, August 16, 2016; 10.1038/bjc.2016.248 Abstract | Full Text Increased pancreatic cancer risk following radiotherapy for testicular cancer Michael Hauptmann, Tom Børge Johannesen, Ethel S Gilbert, Marilyn Stovall, Flora E van Leeuwen, Preetha Rajaraman, Susan A Smith, Rita E Weathers, Berthe M P Aleman, Michael Andersson, Rochelle E Curtis, Graça M Dores, Joseph F Fraumeni Jr, Per Hall, Eric J Holowaty, Heikki Joensuu, Magnus Kaijser, Ruth A Kleinerman, Frøydis Langmark, Charles F Lynch, Eero Pukkala, Hans H Storm, Leila Vaalavirta, Alexandra W van den Belt-Dusebout, Lindsay M Morton, Sophie D Fossa and Lois B Travis Br J Cancer 2016 115: 901-908; advance online publication, September 6, 2016; 10.1038/bjc.2016.272 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.